Open AccessMaculopapular erythema caused by previously used chemotherapy drugs after nivolumab treatment for malignant mesothelioma
Author(s) -
Kanai Junko,
Nagaoka Sayuko,
Hayashi Yumeko,
Hayashi Shujiro
Publication year - 2021
Publication title -
journal of cutaneous immunology and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.127
H-Index - 1
ISSN - 2574-4593
DOI - 10.1002/cia2.12196
Subject(s) - nivolumab , medicine , chemotherapy , mesothelioma , drug , erythema , adverse effect , oncology , dermatology , immunotherapy , pharmacology , pathology , cancer
Currently, an increasing number of cutaneous adverse reactions resulting from the use of programmed cell death protein 1 (PD‐1) inhibitors have been described. We present a case in which drug eruption had not appeared before nivolumab therapy, but was induced by the same chemo drug after nivolumab therapy.